Zhang Eric Y, Knipp Gregory T, Ekins Sean, Swaan Peter W
Division of Pharmaceutics, The Ohio State University, 500 West 12th Avenue, Columbus, OH 43210-1291, USA.
Drug Metab Rev. 2002 Nov;34(4):709-50. doi: 10.1081/dmr-120015692.
Solute carrier (SLC) proteins have critical physiological roles in nutrient transport and may be utilized as a mechanism to increase drug absorption. However, we have little understanding of these proteins at the molecular level due to the absence of high-resolution crystal structures. Numerous efforts have been made in characterizing the peptide transporter (PepT1) and the apical sodium dependent bile acid transporter (ASBT) that are important for both their native transporter function as well as targets to increase absorption and act as therapeutic targets. In vitro and computational approaches have been applied to gain some insight into these transporters with some success. This represents an opportunity for optimizing molecules as substrates for the solute transporters and providing a further screening system for drug discovery. Clearly the future growth in knowledge of SLC function will be led by integrated in vitro and in silico approaches.
溶质载体(SLC)蛋白在营养物质运输中具有关键的生理作用,可作为增加药物吸收的一种机制。然而,由于缺乏高分辨率晶体结构,我们对这些蛋白在分子水平上了解甚少。在表征肽转运体(PepT1)和顶端钠依赖性胆汁酸转运体(ASBT)方面已经做了大量工作,它们对于其天然转运体功能以及作为增加吸收的靶点和治疗靶点都很重要。体外和计算方法已被应用于深入了解这些转运体并取得了一些成功。这为优化作为溶质转运体底物的分子以及为药物发现提供进一步的筛选系统提供了机会。显然,SLC功能知识的未来增长将由体外和计算机模拟相结合的方法引领。